| P50 | author | Andrea Onetti Muda | Q56428257 |
| | Frank Bienaimé | Q56959308 |
| | Gérard Friedlander | Q39659602 |
| P2093 | author name string | Tobias B Huber | |
| | Mario Pende | |
| | Andrea Onetti Muda | |
| | Fabiola Terzi | |
| | Marco Pontoglio | |
| | Christophe Legendre | |
| | Konstantinos Giannakakis | |
| | Guillaume Canaud | |
| | Amandine Viau | |
| | Stefan Zschiedrich | |
| | Clément Nguyen | |
| | Caroline Treins | |
| | Sophie Berissi | |
| | Martine Burtin | |
| | William Baron | |
| P2860 | cites work | Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 |
| | Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity | Q24598427 |
| | AKT/PKB signaling: navigating downstream | Q24657857 |
| | Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta | Q24669877 |
| | Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice | Q43726502 |
| | Sirolimus interacts with pathways essential for podocyte integrity | Q45151652 |
| | Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. | Q46510650 |
| | Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis | Q46522437 |
| | Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach | Q46616535 |
| | The Notch pathway in podocytes plays a role in the development of glomerular disease | Q46725170 |
| | Proteinuria following a switch from calcineurin inhibitors to sirolimus | Q46825307 |
| | Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. | Q46886156 |
| | The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. | Q51547435 |
| | Modification of kidney barrier function by the urokinase receptor. | Q53510545 |
| | mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome. | Q54351691 |
| | Signaling in regulation of podocyte phenotypes. | Q54774137 |
| | Podocyte-specific expression of cre recombinase in transgenic mice | Q57740867 |
| | Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass | Q59531350 |
| | Opposing Roles for Akt1 and Akt2 in Rac/Pak Signaling and Cell Migration | Q60155829 |
| | Age-associated changes in renal glomeruli of mice | Q69627600 |
| | Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis | Q80433109 |
| | Effects of rapamycin on active Heymann nephritis | Q80482229 |
| | Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death | Q81007653 |
| | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis | Q26995926 |
| | Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome | Q28256662 |
| | Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 |
| | Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions | Q28345280 |
| | Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis | Q28504659 |
| | Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling | Q28611533 |
| | Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) | Q29615537 |
| | Role of mTOR in podocyte function and diabetic nephropathy in humans and mice | Q30500731 |
| | Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal | Q33359653 |
| | Induction of B7-1 in podocytes is associated with nephrotic syndrome | Q33785088 |
| | The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. | Q33943247 |
| | Proteinuria: an enzymatic disease of the podocyte? | Q33943310 |
| | Lipocalin 2 is essential for chronic kidney disease progression in mice and humans | Q34245315 |
| | TGF-alpha mediates genetic susceptibility to chronic kidney disease. | Q34534909 |
| | Hyperfiltration and glomerulosclerosis | Q35110865 |
| | Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury | Q35126310 |
| | Inhibition of podocyte FAK protects against proteinuria and foot process effacement. | Q35153198 |
| | Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes | Q35916016 |
| | Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT. | Q35937270 |
| | Pathways to nephron loss starting from glomerular diseases-insights from animal models | Q36021181 |
| | Podocyte-specific loss of Cdc42 leads to congenital nephropathy | Q36050935 |
| | The podocyte's response to injury: role in proteinuria and glomerulosclerosis | Q36474870 |
| | Podocytes in culture: past, present, and future | Q36801026 |
| | Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton | Q36931220 |
| | The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors | Q37089913 |
| | Intracellular signaling by Akt: bound to be specific | Q37193392 |
| | Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria | Q37330532 |
| | Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes. | Q39719517 |
| | Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease | Q39912709 |
| | mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes | Q39914641 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase | Q40533718 |
| | Progression of renal disease and renal hypertrophy | Q40543219 |
| | Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin | Q40545315 |
| | mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice | Q41912848 |
| | Insulin signaling to the glomerular podocyte is critical for normal kidney function | Q42110064 |
| | Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 | Q42592859 |
| P433 | issue | 10 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 1288-1296 | |
| P577 | publication date | 2013-09-22 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | AKT2 is essential to maintain podocyte viability and function during chronic kidney disease | |
| P478 | volume | 19 | |